0001637715-18-000001.txt : 20180108 0001637715-18-000001.hdr.sgml : 20180108 20180108133109 ACCESSION NUMBER: 0001637715-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 EFFECTIVENESS DATE: 20180108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302643 FILM NUMBER: 18515802 BUSINESS ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 BUSINESS PHONE: 619-733-3852 MAIL ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 D 1 primary_doc.xml X0708 D LIVE 0001637715 Reneo Pharmaceuticals, Inc. 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 858-346-1755 DELAWARE None None Corporation true 2014 Michael Grey 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 Executive Officer Director Niall O'Donnell 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 Executive Officer Director Wendy Johnson 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 Executive Officer Scott Weiner 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 Director Ed Mathers 12730 High Bluff Drive, Suite 160 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2017-12-22 true true false 0 51994684 21994682 30000002 Total Amount Sold includes amounts paid pursuant to conversion of indebtedness. false 16 0 0 0 false Reneo Pharmaceuticals, Inc. Niall O'Donnell Niall O'Donnell President and CEO 2018-01-08